Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

IONICON Launches the New Ultra-sensitive PTR-QiTOF Trace VOC Analyzer

Published: Wednesday, June 04, 2014
Last Updated: Wednesday, June 04, 2014
Bookmark and Share
Welcome to the future: 25x more sensitive than the world's bestselling PTR-TOFMS instrument.

IONICON Analytik has unveiled its new PTR-TOFMS series flagship instrument: the PTR-QiTOF.

Featuring a Quadrupole ion guide (Qi), the PTR-QiTOF achieves a performance, no other commercial PTR-TOFMS system has ever been able to demonstrate before.

Scientists can expect up to 25x more sensitivity, one order of magnitude lower detection limit and 20% higher mass resolution than the world's current bestselling and up to now also best-performing PTR-TOFMS instrument.

The market-leading specifications of the new PTR-QiTOF are the result of our continuous investment in innovation and herald a new generation of IONICON PTR-TOFMS technology:

Using a specially crafted high-resolution time of flight (TOF) mass spectrometer including the new Quadrupole ion guide (Qi) in combination with the refined IONICON PTR technology, the PTR-QiTOF achieves a mass resolution of more than 6000 (up to 10,000 m/Δm FWHM), a limit of detection well below 1 pptv (in 30 sec), and an unmatched sensitivity of more than 1500 (up to 4500 cps/ppbv).

This boost in sensitivity is especially beneficial for cutting edge applications like eddy-covariance flux measurements, where ultra-low VOC concentrations have to be quantified with more than 10 Hz.

The high time-resolution and sensitivity of IONICON PTR-TOF instruments enable flux measurements of biogenic VOCs, providing new insights to our understanding of the atmospheric VOC budget by studying active atmosphere-ecosystem exchange of a vast number of BVOCs.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Thursday, August 20, 2015
IONICON Selects RJ Lee Group as Exclusive U.S. Distributor
RJ Lee Group has become the exclusive U.S. distribution partner for IONICON’s Trace Gas Analysis products.
Thursday, June 27, 2013
World’s Leading PTR-MS Company IONICON Integrates its Subsidiary
IONICON to celebrate its 15th anniversary in July 2013.
Friday, June 07, 2013
RJ Lee Group's Mobile Lab is Now Deployed for Real-Time VOCs Monitoring
RJ Lee Group equipes mobile lab with IONICON PTR-MS and provides rapid, mobile monitoring of organic contamination and leaks caused by hurricane "Sandy".
Thursday, November 15, 2012
IONICON Announces New Distribution Partner for Australia and New Zealand
IONICON and Ecotech are teaming up.
Wednesday, August 22, 2012
IONICON Announces New Distribution Partner for Singapore, Malaysia and Thailand
IONICON and Omega join efforts in Southeast Asia.
Monday, April 30, 2012
IONICON US Starts its Operations in North America
Effective and fast local PTR-MS sales and support for US customers now directly available from IONICON US, Inc., New Jersey.
Thursday, October 20, 2011
First Results of CERN's CLOUD Experiment Published in NATURE
The CLOUD experiment has been designed to study the effect of cosmic rays on the formation of atmospheric aerosols under controlled laboratory conditions.
Thursday, August 25, 2011
IONICON Announces New Distribution Partner for India
IONICON and MARS Bioanalytical have teamed up to target the Indian market.
Sunday, July 24, 2011
IONICON Appoints New CEO
Mr. Lukas MÄRK stepped in as CEO IONICON Analytik GmbH on June 1, 2011.
Monday, July 11, 2011
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Analysis Technique for Chiral Activity in Molecules
Professor Hyunwoo Kim of the Chemistry Department and his research team have developed a technique that can easily analyze the optical activity of charged compounds by using nuclear magnetic resonance (NMR) spectroscopy.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Best Test to Diagnose Strangles in Horses Identified
New research by Dr. Ashley Boyle of New Bolton Center’s Equine Field Service team shows that the best method for diagnosing Strangles in horses is to take samples from a horse’s guttural pouch and analyze them using a loop-mediated amplification (LAMP) polymerase chain reaction (PCR) test.
Tardigrade's Are DNA Master Thieves
Tardigrades, nearly microscopic animals that can survive the harshest of environments, including outer space, hold the record for the animal that has the most foreign DNA.
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Antibiotics on Our Plates 'Could Lead to Health Catastrophe'
Two medical experts from The University of Queensland are urging China to curb its use of antibiotics in animals to avoid what could be a ‘major health catastrophe’ for humans.
The Secret Behind the Power of Bacterial Sex
Migration between different communities of bacteria is the key to the type of gene transfer that can lead to the spread of traits such as antibiotic resistance, according to researchers at Oxford University.
Farming’s in Their DNA
Ancient genomes reveal natural selection in action.
Personalized Drug Screening for Multiple Myeloma Patients
A personalized method for testing the effectiveness of drugs that treat multiple myeloma may predict quickly and more accurately the best treatments for individual patients with the bone marrow cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos